|
|
||||||||
(Received for publication, November 18, 1994; and in revised form, January 25, 1995) The molecular basis for the treatment of human herpesviruses
with nucleoside drugs is the phosphorylation of these drugs by the
viral-encoded thymidine kinases. In order to better understand the
structural and enzymatic mechanisms by which herpesviral thymidine
kinases recognize their substrates, photoaffinity labeling with
[
Volume 270,
Number 13,
Issue of March 31, 1995 pp. 7055-7060
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
-
P]5-azido-2`-deoxyuridine-5`-monophosphate
and [
-
P]8-azidoadenosine-5`-triphosphate
was used to characterize the thymidine, thymidylate, and ATP active
sites of the herpes simplex virus-1 (HSV-1) thymidine kinase. For this
study, HSV-1 thymidine kinase and a site-specific mutant enzyme (C336Y,
known to confer acyclovir resistance) were expressed in bacteria and
purified by a rapid, two-step protocol. The specificity of
photoaffinity labeling of these HSV-1 thymidine kinases was
demonstrated by the ability of site-directed substrates such as
thymidine, thymidylate, acyclovir, 5-bromovinyl-2`-deoxyuridine, and
ATP to inhibit photoinsertion. Differences in inhibition patterns of
photoaffinity labeling correlated with kinetic differences between the
wild-type and C336Y HSV-1 thymidine kinases. Cumulative results suggest
that the acyclovir-resistant cysteine 336 mutation primarily affects
the ATP binding site; yet it also leads to alteration in the binding
affinity of nucleoside drugs in the thymidine site. In this study,
azidonucleotide photoaffinity analogs are shown to be effective tools
for studying the active-site environment of HSV-1 thymidine kinase and
related site-specific mutants.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. E. Mercer, C. E. Ahn, A. Coke, C. M. Compadre, and R. R. Drake Mutation of herpesvirus thymidine kinase to generate ganciclovir-specific kinases for use in cancer gene therapies Protein Eng. Des. Sel., November 1, 2002; 15(11): 903 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bestman-Smith, I. Schmit, B. Papadopoulou, and G. Boivin Highly Reliable Heterologous System for Evaluating Resistance of Clinical Herpes Simplex Virus Isolates to Nucleoside Analogues J. Virol., April 1, 2001; 75(7): 3105 - 3110. [Abstract] [Full Text] |
||||
![]() |
R. R. Drake, N. Neamati, H. Hong, A. A. Pilon, P. Sunthankar, S. D. Hume, G. W. A. Milne, and Y. Pommier Identification of a nucleotide binding site in HIV-1 integrase PNAS, April 14, 1998; 95(8): 4170 - 4175. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mao, T. M. Rechtin, R. Jones, A. A. Cantu, L. S. Anderson, A. Radominska, M. P. Moyer, and R. R. Drake Synthesis of a Photoaffinity Analog of 3`-Azidothymidine, 5-Azido-3`-azido-2`,3`-dideoxyuridine J. Biol. Chem., June 9, 1995; 270(23): 13660 - 13664. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |